Isolation, establishment, and characterization of ex vivo equine melanoma cell cultures

In Vitro Cellular and Developmental Biology - Animal

Volumn 45, Issue 3-4, 2009, Pages 152-162

  Chapman, Sarah W Kamau ^a   Metzger, Nadine ^a   Grest, Paula ^a   Feige, Karsten ^b   Von Rechenberg, Brigitte ^c   Auer, Jörg A ^a   Hottiger, Michael O ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^c VETSUISSE FACULTY UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Characterization; Equine primary melanoma cultures; MAGE 1; MAGE 3; Melan A; Melanoma associated antigen

Indexed keywords

CYCLINE; TUMOR ANTIGEN;

ANIMAL; ARTICLE; CELL SEPARATION; CONFOCAL MICROSCOPY; FLOW CYTOMETRY; HORSE; MELANOMA; METABOLISM; METHODOLOGY; PATHOLOGY; STAINING; TUMOR CELL CULTURE; WESTERN BLOTTING;

ANIMALS; ANTIGENS, NEOPLASM; BLOTTING, WESTERN; CELL SEPARATION; FLOW CYTOMETRY; HORSES; MELANOMA; MICROSCOPY, CONFOCAL; PROLIFERATING CELL NUCLEAR ANTIGEN; STAINING AND LABELING; TUMOR CELLS, CULTURED;

EID: 67549107663     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11626-008-9156-3     Document Type: Article

References (31)

1. Ben-Izhak O.; Bar-Chana M.; Sussman L.; Dobiner V.; Sandbank J.; Cagnano M.; Cohen H.; Sabo E. Ki67 antigen and PCNA proliferation markers predict survival in anorectal malignant melanoma. Histopathology. 41: 519-525; 2002. doi:10.1046/ j.1365-2559.2002.01444.x.
2. Boon T.; van der Bruggen P. Human tumor antigens recognized by T lymphocytes. J. Exp. Med. 183: 725-729; 1996. doi:10.1084/ jem.183.3.725.
3. Busam K. J.; Iversen K.; Berwick M.; Spagnoli G. C.; Old L. J.; Jungbluth A. A. Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: frequency of expression and correlation with prognostic parameters. Mod. Pathol. 13: 459-465; 2000. doi:10.1038/modpathol.3880078.
4. Cox J. H.; DeBowes R. M.; Leipold H. W. Congenital malignant melanoma in two foals. J. Am. Vet. Med. Assoc. 194: 945-947; 1989.
5. van Dinten L. C.; Pul N.; van Nieuwpoort A. F.; Out C. J.; Jager M. J.; van den Elsen P. J. Uveal and cutaneous melanoma: shared expression characteristics of melanoma-associated antigens. Invest. Ophthalmol. Vis. Sci. 46: 24-30; 2005. doi:10.1167/iovs.04-0961.
6. Freeman, D. E. In: Auer J. A., Stick J. A. (eds) Equine surgery. WB Saunder, Philadelphia, pp 286-293; 1999.
7. Frederick D. Excision of melanomas in the horse. J. Am. Vet. Med. Assoc. 196: 1201-1202; 1990.
8. Goetz T. E.; Long M. Treatment of melanoma in horses. Comp. Cont. Ed. Pract. Vet. 15: 608-610; 1993.
9. Goetz T. E.; Ogilvie G. K.; Keegan K. G.; Johnson P. J. Cimetidine for treatment of melanomas in three horses. J. Am. Vet. Med. Assoc. 196: 449-452; 1990.
10. Halaban R.; Alfano F. D. Selective elimination of fibroblasts from cultures of normal melanocytes. In Vitro. 20: 447-450; 1984. doi:10.1007/BF02619590.
11. Hanke S. M.; Kief S.; Leuwer R.; Koch U.; Moll I.; Brandner J. M. In vitro isolation and cell culture of vestibular inner ear melanocytes. Audiol. neuro-otol. 10: 191-200; 2005. doi:10.1159/ 000084840.
12. Heinzerling L.; Feige K.; Rieder S.; Akens M. K.; Dummer R.; Stranzinger G.; Moelling K. Tumor regression induced by intratumoral injection of DNA coding for human interleukin 12 into melanoma metastases in gray horses. J. Mol. Med. 78: 692-702; 2001. doi:10.1007/s001090000165.
13. Hofbauer G. F.; Geertsen R.; Laine E.; Burg G.; Dummer R. Impact of interferons on the expression of melanoma-associated antigens in melanoma short-term cell cultures. Melanoma Res. 11: 213-218; 2001. doi:10.1097/00008390- 200106000-00002.
14. Jeglum, K. Melanomas, current therapy in equine medicine, In: Robinson N. E. (eds) Saunders, pp 399-400; 1999.
15. Kelman Z. PCNA: structure, functions and interactions. Oncogene. 14: 629-640; 1997. doi:10.1038/sj.onc.1200886.
16. Koenig A.; Wojcieszyn J.; Weeks B. R.; Modiano J. F. Expression of S100a, vimentin, NSE, and melan A/MART-1 in seven canine melanoma cells lines and twenty-nine retrospective cases of canine melanoma. Vet. Pathol. 38: 427-435; 2001. doi:10.1354/ vp.38-4-427.
17. MacGillivray K. C.; Sweeney R. W.; Del Piero F. Metastatic melanoma in horses. J. Vet. Intern. Med. 16: 452-456; 2002. doi:10.1892/0891-6640(2002) 016<0452:MMIH>2.3.CO;2.
18. McFadyean J. Equine melanomatosis. J. Comp. Pathol. Ther. 46: 186-204; 1933.
19. Murer K.; Urosevic M.; Willers J.; Selvam P.; Laine E.; Burg G.; Dummer R. Expression of Melan-A/MART-1 in primary melanoma cell cultures has prognostic implication in metastatic melanoma patients. Melanoma Res. 14: 257-262; 2004. doi:10.1097/01.cmr.0000136713.21029.56.
20. Ritt M. G.; Mayor J.; Wojcieszyn J.; Smith R.; Barton C. L.; Modiano J. F. Sustained nuclear localization of p21/WAF-1 upon growth arrest induced by contact inhibition. Cancer. Lett. 158: 73-84; 2000. doi:10.1016/S0304-3835(00) 00507-3.
21. Ritt M. G.; Wojcieszyn J.; Modiano J. F. Functional loss of p21/Waf-1 in a case of benign canine multicentric melanoma. Vet. Pathol. 35: 94-101; 1998.
22. Rodríguez M.; Garcia-Barona J.; Pera L.; Castano M.; Rodriguez A. Grey horse melanotic condition: a pigmentary disorder. J. Eq. Vet. Sci. 17: 677-681; 1997. doi:10.1016/S0737-0806(97)80270-5.
23. Rowe E. L.; Sullins K. E. Excision as treatment of dermal melanomatosis in horses: 11 cases (1994-2000). J. Am. Vet. Med. Assoc. 225: 94-96; 2004. doi:10.2460/javma.2004.225.94.
24. Seltenhammer M. H.; Heere-Ress E.; Brandt S.; Druml T.; Jansen B.; Pehamberger H.; Niebauer G. W. Comparative histopathology of grey-horse-melanoma and human malignant melanoma. Pigment Cell Res. 17: 674-681; 2004. doi:10.1111/j.1600-0749.2004.00192.x.
25. Scott D. W.; Miller W. H. Neoplastic diseases. Equine Dermatology. Saunders, Philadelphia, PA, pp 764-773; 2003.
26. Stähli, P. Einsatz von Interleukin-12 und Interleukin-18 kodierender Plasmid-DNA zur Therapie von Melanomen beim Schimmel, Dissertation; Vetsuisse-Faculty, University of Zurich. 2005.
27. Théon A. P.; Pascoe J. R.; Carlson G. P.; Krag D. N. Intratumoral chemotherapy with cisplatin in oily emulsion in horses. J. Am. Vet. Med. Assoc. 202: 261-267; 1993.
28. Urosevic M.; Braun B.; Willers J.; Burg G.; Dummer R. Expression of melanoma-associated antigens in melanoma cell cultures. Exp. Dermatol. 14: 491-497; 2005. doi:10.1111/j.0906-6705.2005.00305.x.
29. Valentine B. A. Equine melanocytic tumors: A retrospective study of 53 horses (1988 to 1991). J. Vet. Int. Med. 9: 291-297; 1995.
30. Warnick L. D.; Graham M. E.; Valentine B. A. Evaluation of cimetidine treatment for melanomas in seven horses. Equine. Pract. 17: 16-22; 1995.
31. Wolfe L. G.; Oliver J. L.; Smith B. B.; Toivio-Kinnucan M. A.; Powers R. D.; Brawner W. R.; Henderson R. A.; Hankes G. H. Biologic characterization of canine melanoma cell lines. Am. J. Vet. Res. 48: 1642-1648; 1987.